GOSSAMER BIO, INC.
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | — | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $44.1M | $262.0K |
| Operating Income | $-149.0M | $-6.7M |
| Operating Margin | — | — |
| Interest Expense | $12.0K | — |
| Pretax Income | $-147.0M | $6.8M |
| Income Tax Expense | $0 | $0 |
| Net Income | $-147.0M | $-6.8M |
| Net Margin | — | — |
| EPS (Basic) | $-22.59 | $-0.74 |
| EPS (Diluted) | $-22.59 | $-0.74 |
| Shares Outstanding (Basic) | 8.1M | — |
| Shares Outstanding (Diluted) | 8.1M | — |
| Dividends Per Share | — | — |